Literature DB >> 2523900

Early lymphocyte transformation abnormalities in human immunodeficiency virus infection.

D J Ridley1, R W Houk, M J Reid, R N Boswell.   

Abstract

Two hundred twelve patients with enzyme immunoassay and Western blot confirmation of human immunodeficiency virus (HIV) infection were evaluated with anergy panel, lymphocyte cell surface phenotyping, lymphocyte transformation, and serum immunoglobulins. Mitogen responses were used to develop a lymphocyte transformation index (LTI) comparing the summation of each individual's response to its normal control. By multiple regression, anergy panel, absolute CD4 level, and LTI show a progressive decline and IgA shows a progressive increase when correlated with a worsening Walter Reed (WR) classification (R = 0.84). Lymphocyte transformation is first abnormal in WR class 1, absolute CD4 in WR class 3, and anergy and serum IgA in WR class 4. The above markers are useful to assess immunologic function in HIV infection. Lymphocyte transformation abnormalities precede other immunologic deficits in HIV positive patients. Serial evaluation of these markers may help define the immunologic response and natural history of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523900     DOI: 10.1007/bf00916939

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  19 in total

Review 1.  Pathogenesis of infection with human immunodeficiency virus.

Authors:  D D Ho; R J Pomerantz; J C Kaplan
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

2.  The Walter Reed staging classification for HTLV-III/LAV infection.

Authors:  R R Redfield; D C Wright; E C Tramont
Journal:  N Engl J Med       Date:  1986-01-09       Impact factor: 91.245

Review 3.  The acquired immune deficiency syndrome: laboratory findings, clinical features, and leading hypotheses.

Authors:  W El-Sadr; R Stahl; G Sidhu; S Zolla-Pazner
Journal:  Diagn Immunol       Date:  1984

4.  Lymphocytic subsets in the acquired immunodeficiency syndrome.

Authors:  S Gupta; K Licorish; G Garthfield
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

5.  Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome.

Authors:  S Vadhan-Raj; G Wong; C Gnecco; S Cunningham-Rundles; M Krim; F X Real; H F Oettgen; S E Krown
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

6.  Flow cytometric analysis of lymphocyte phenotypes in AIDS using monoclonal antibodies and simultaneous dual immunofluorescence.

Authors:  D P Stites; C H Casavant; T M McHugh; A R Moss; S L Beal; J L Ziegler; A M Saunders; N L Warner
Journal:  Clin Immunol Immunopathol       Date:  1986-02

7.  Immunologic studies of the acquired immune deficiency syndrome: relationship of immunodeficiency to extent of disease.

Authors:  E M Hersh; J M Reuben; P W Mansell; A Rios; J U Gutterman; G Munn; J L Murray; S P Spector; A L Goldstein; G R Newell
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

8.  Unexplained lymphadenopathy in homosexual men. A longitudinal study.

Authors:  D B Fishbein; J E Kaplan; T J Spira; B Miller; L B Schonberger; P F Pinsky; J P Getchell; V S Kalyanaraman; J S Braude
Journal:  JAMA       Date:  1985-08-16       Impact factor: 56.272

9.  Serum immunoglobulin elevations in the acquired immunodeficiency syndrome (AIDS): IgG, IgA, IgM, and IgD.

Authors:  Q Chess; J Daniels; E North; N T Macris
Journal:  Diagn Immunol       Date:  1984

10.  Immunological studies in the acquired immunodeficiency syndrome. II. Active suppression or intrinsic defect--investigated by mixing AIDS cells with HLA-DR identical normal cells.

Authors:  B Hofmann; N Odum; B K Jakobsen; P Platz; L P Ryder; J O Nielsen; J Gerstoft; A Svejgaard
Journal:  Scand J Immunol       Date:  1986-06       Impact factor: 3.487

View more
  2 in total

1.  Do beta-chemokines have clinical relevance in HIV infection?

Authors:  C E Mackewicz; E Barker; G Greco; G Reyes-Teran; J A Levy
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  HIV-induced deletion of antigen-specific T cell function is MHC restricted.

Authors:  F Manca; A Newell; M Valle; J Habeshaw; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.